Developing a vaccine for human rhinoviruses

Journal Title: Journal of Vaccines & Immunization - Year 2014, Vol 2, Issue 3

Abstract

Rhinoviruses (RV’s) are common human pathogens of the respiratory tract being the most frequent cause of mild diseases of the upper respiratory tract (common cold) but more importantly they are a major initiator of acute exacerbations of chronic airway diseases. Infections can be life threatening in the latter context however RV -induced common colds have an associated economic cost from loss of productivity due to absence from work or school. There are no appropriate antiviral therapies available and vaccine strategies have failed because of the large number of viral serotypes and the lack of cross-serotype protection generated. Here, approaches past and present for development of a vaccine to these widespread human pathogens are highlighted.

Authors and Affiliations

McLean GR

Keywords

Related Articles

Home-based vaccination records and hypothetical cost-savings due to avoidance of re-vaccinating children

As national immunization programmes, particularly those in low- and middle-income countries where administrative recording of services received is often absent or sub-optimal, enter a period of rapidly paced change with...

An evaluation of the indirect cohort method to estimate the effectiveness of the pneumococcal polysaccharide vaccine

We examined the validity of the indirect cohort method as a rapid assessment tool to estimate pneumococcal polysaccharide vaccine effectiveness (VE). Using evidence from published clinical trials, we reviewed the primary...

Comparison of the live attenuated mumps vaccine (Miyahara strain) with its preattenuated parental strain

Live attenuated mumps vaccines have been developed by passaging the field isolates in cells that differ from the natural host. To study mumps viral (MuV) attenuation at the genomic level, we compared a live attenuated mu...

Developing a vaccine for human rhinoviruses

Rhinoviruses (RV’s) are common human pathogens of the respiratory tract being the most frequent cause of mild diseases of the upper respiratory tract (common cold) but more importantly they are a major initiator of acute...

Silk-based microneedle transdermal immunization with EV71 vaccines elicits potent immune responses in mice

Hand, foot, and mouth disease (HFMD), caused by EV71 viral infection, has emerged as a serious public health concern in the Asia-Pacific region. The lack of effective treatment has led to a focus on controlling EV71 epid...

Download PDF file
  • EP ID EP566691
  • DOI 10.14312/2053-1273.2014-3
  • Views 77
  • Downloads 0

How To Cite

McLean GR (2014). Developing a vaccine for human rhinoviruses. Journal of Vaccines & Immunization, 2(3), 16-20. https://europub.co.uk/articles/-A-566691